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Introduction 
 
Maternal anti-mullerian hormone 
declines sharply between 13-15 weeks, 
likely as a result of feto-placental 
signaling. Fetal AMH levels are known 
to be widely disparate after the first 
trimester, with high levels in male and 
absent levels in female. However, it is 
unclear as to whether differing fetal 
AMH levels influence the pattern of 
change of maternal AMH. Our objective 
was to examine AMH throughout 
gestation to determine if the maternal 
concentration varies according to the 
gender of the fetus.  
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Methods 
 
De-identified maternal plasma samples 
along with demographic and pregnancy 
outcome data were obtained from the 
IRB-approved Maternal-Fetal Tissue 
Bank at the University of Iowa. All 
women were ≥18 years old and had an 
uncomplicated singleton delivery at 
≥37weeks. AMH was tested using the 
GenII AMH ELISA assay (Beckman 
Coulter). Bicinchoninic acid (BCA) assay 
(Pierce) was used to measure total 
protein. AMH was normalized to total 
protein prior to analysis. Mean AMH and 
AMH by gestational age between 
women carrying boys vs. girls was 
compared with logistic regression 
modeling.  
 
Results 
 
154 samples from 107 women (51 
males and 56 females) were analyzed. 
Because of multiple sampling, 78 
samples were from boys and 76 
samples were from girls. No differences 
in maternal age, gestational age at 
delivery, or number of samples from 
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each gestational category between 
sexes. Mean AMH levels were not 
different if carrying a male vs. female 
fetus (p=0.12). However, when stratified 
by gestational age, mean AMH (±SEM) 
at 11-15 weeks was significantly higher 
in women with male fetuses 
(2.0±0.30ng/mL) vs. female fetuses 
(0.94±0.20ng/mL) (p=0.008).  
 
Conclusion 
 
AMH falls in pregnancy between 11-15 
weeks regardless of fetal sex; however, 
maternal AMH is significantly higher in 
pregnancies carrying male compared to 
female fetuses. This may represent a 
sexually dimorphic response in the 
ovary to feto-placental signaling. 
 
